Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInterserve Regulatory News (IRV)

  • There is currently no data for IRV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Deleveraging Plan

6 Feb 2019 07:00

RNS Number : 2184P
Interserve PLC
06 February 2019
 

 

 

 

6 February 2019

 

Progress on Deleveraging Plan

 

 

Following its 21 December 2018 announcement, the Board is pleased to provide further details on its Deleveraging Plan.

 

The key commercial terms of the Deleveraging Plan have been agreed in principle with all of Interserve's lenders, bonding providers and the Pension Trustee.

 

The Board believes the Deleveraging Plan will provide Interserve with a strong balance sheet and the platform to deliver on its strategy.

 

Debbie White, CEO of Interserve, said:

 

"Agreeing the key commercial terms of the Deleveraging Plan with our lenders, bonding providers and Pension Trustee is a significant step forward in our plans to strengthen the balance sheet. The Board believes that this agreement will secure a strong future for Interserve. This proposal has been achieved following a long period of intensive negotiation and has the support of our financial stakeholders and Government. Its successful implementation is critical to the Interserve Group's future and all of its stakeholders. The Deleveraging Plan will, alongside our 'Fit for Growth' transformation programme, place us in a strong position to deliver our strategy, be competitive in the marketplace and provide a secure future for the Interserve Group's employees, customers and suppliers."

In summary:

 

· The Deleveraging Plan is expected to result in Interserve Group's pro forma net debt reducing to c.£275 million achieved through issuing c.£480 million of new Interserve equity;

 

· RMDK will remain part of the consolidated Interserve Group. As part of the transaction, £350 million of existing debt will be allocated to RMDK, of which £169 million will be cash-pay and £181 million will be converted into a subordinated non-cash pay debt instrument. The debt allocated to RMDK will be non-recourse to the rest of Interserve Group and have maturities extended to 2023;

 

· Interserve Group excluding RMDK will have a pro forma net cash position of c.£60 million, i.e. leverage below zero;

 

· Existing lenders will provide an additional £75 million of new liquidity through the provision of a new debt facility with a maturity of 2022;

 

· The bonding providers will provide additional bonding facilities to Interserve as required by Interserve's business plan;

 

· The new Interserve equity will be provisionally placed with existing lenders and subject to claw back in full by existing Interserve shareholders through a fully pre-emptive open offer (the "Placing and Open Offer");

 

· Any equity issued to existing lenders, as part of the Placing and Open Offer, will be subscribed for by the conversion of senior debt into new Interserve ordinary shares;

 

· It is anticipated that the shares issued through the Placing and Open Offer will account for 97.5 per cent. of the ordinary share capital of Interserve as enlarged by the Placing and Open Offer;

 

· All proceeds from the equity issue will be used to repay Interserve senior debt; and

 

· Net cash-pay leverage of the Interserve Group (excluding the RMDK non-cash pay debt instrument) will be reduced to less than 1x EBITDA and total net leverage (including the RMDK non-cash pay debt instrument) reduced to approximately 2x EBITDA.

Interserve expects to launch the finalised Deleveraging Plan in the next few weeks; the Deleveraging Plan will be subject to approval by Interserve's shareholders.

 

Whilst Interserve's objective remains to implement a fully consensual transaction, Interserve is also actively preparing alternative plans to ensure the proposed transaction can be implemented in the event that shareholder approval is not forthcoming.

 

END

 

This announcement contains forward-looking statements in respect of the Interserve Group and its Deleveraging Plan. By their nature, these statements involve uncertainty, known and unknown risks and other factors and therefore assurance cannot be given that any particular expectation will be met. In particular, while Interserve continues to work towards the implementation of the Deleveraging Plan in the first quarter of 2019, there can be no assurance that the Deleveraging Plan will be implemented unless and until agreements have been reached with several parties and until all conditions (which include documentation, credit and investment committee approval and final due diligence) are satisfied.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION RELATING TO INTERSERVE PLC.

LEI: 549300MVYY4EZCRFHZ09

 

For further information please contact:

 

Jonathan Refoy +44 (0) 7880 315877

Interserve plc

 

Martin Robinson +44 (0) 207 3534200

Tulchan Communications

 

 

About Interserve

 

Interserve is one of the world's foremost support services and construction companies. Everything we do is shaped by our core values. We are a leader in innovative and sustainable outcomes for our clients and a great place to work for our people. We offer advice, design, construction, equipment, facilities management and frontline public services. We are headquartered in the UK and FTSE-listed. We have gross revenues of £3.7 billion and a workforce of circa 74,000 people worldwide.

www.interserve.com

 

For news follow @interservenews 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRLIFERFEIRIIA
Date   Source Headline
9th Sep 20163:37 pmRNSDirector/PDMR Shareholding
25th Aug 20169:33 amRNSPublication of Half-Year Report 2016
24th Aug 20167:00 amRNSCONTRACT WIN
10th Aug 20167:00 amRNSHalf-Year Results
9th Aug 201610:59 amRNSDirector/PDMR Shareholding
8th Aug 20167:00 amRNSContract Extension
5th Aug 20162:19 pmRNSHolding(s) in Company
15th Jul 20163:31 pmRNSHolding(s) in Company
12th Jul 20162:47 pmRNSDirector/PDMR Shareholding
1st Jul 20163:21 pmRNSBlock listing Interim Review
28th Jun 20167:00 amRNSContract Win
14th Jun 20161:04 pmRNSDirector/PDMR Shareholding
27th May 20163:51 pmRNSDirector/PDMR Shareholding
26th May 20163:48 pmRNSDirector/PDMR Shareholding
18th May 20167:00 amRNSContract Win
16th May 20162:32 pmRNSDirector/PDMR Shareholding
13th May 20168:38 amRNSHolding(s) in Company
10th May 20162:46 pmRNSResult of AGM
10th May 20167:00 amRNSDirector/PDMR Shareholding
6th May 20167:00 amRNSTrading Update
5th May 20167:00 amRNSBoard Change
3rd May 20167:00 amRNSContract Win
27th Apr 20163:33 pmRNSDirector Declaration
19th Apr 20163:26 pmRNSDirector/PDMR Shareholding
18th Apr 20167:00 amRNSContract Win
14th Apr 20163:25 pmRNSDirector/PDMR Shareholding
13th Apr 20164:16 pmRNSDirector/PDMR Shareholding
6th Apr 20164:48 pmRNSDirector/PDMR Shareholding
31st Mar 201610:23 amRNSDirector/PDMR Shareholding
31st Mar 20169:18 amRNSTotal Voting Rights
30th Mar 20168:36 amRNSPublication of Annual Report
22nd Mar 20163:13 pmRNSAdditional Listing
9th Mar 201610:46 amRNSDirector/PDMR Shareholding
29th Feb 201610:51 amRNSHolding(s) in Company
24th Feb 20167:00 amRNSFinal Results
10th Feb 201612:11 pmRNSDirector/PDMR Shareholding
4th Feb 20164:51 pmRNSHolding(s) in Company
2nd Feb 20169:59 amRNSCirc re Adoption of FRS 101
14th Jan 201610:38 amRNSDirector/PDMR Shareholding
4th Jan 20167:00 amRNSBlocklisting Interim Review
17th Dec 20154:13 pmRNSDirector/PDMR Shareholding
3rd Dec 20151:54 pmRNSHolding(s) in Company
30th Nov 20154:21 pmRNSHolding(s) in Company
13th Nov 20157:05 amRNSAppointment of Chairman-Designate
13th Nov 20157:00 amRNSQ3 Trading Update
10th Nov 20152:05 pmRNSDirector/PDMR Shareholding
5th Nov 20152:02 pmRNSHolding(s) in Company
27th Oct 20152:13 pmRNSDirector/PDMR Shareholding
15th Oct 20159:21 amRNSDirector/PDMR Shareholding
14th Oct 201510:29 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.